Clinical Research from Clinical Investigation Services

Call Today to Qualify

262-925-1280

Open Hours

Monday – Friday 8 am to 5pm

Have you been diagnosed with Atrial Fibrillation (AFib)?

Trial Information:

The LIBREXIA 3002 study by Janssen will compare the effects of an experimental drug, milvexia, to the comparator drug, apixaban, to determine if it is safe and useful in reducing the risk of stroke and blood clots outside the brain (non-central nervous system (CNS) systemic embolism) in participants with atrial fibrillation.

Dr. Geeta Reddy is the leading physician (called the "principal investigator") for this trial at our affiliate clinic in Libertyville, IL. We are currently accepting new patients for this study.

For more information on this clinical trial, please call us at 847-691-3856 and ask to speak to our recruiter Maria.

Study Protocol: JNJ-70033093AFL3002

Title
When Should We Contact You?
When would it be best for a member of our team to contact you? Please select all that apply.
How Did You Hear About Us?
How did you hear about Clinical Investigation Specialists? Please select all that apply.
If you heard about CIS from someone, please let us know! This field is not required. 
CIS Research is a robust, multi-site network of clinical trial sites. This means we are always running many types of research studies. We would like to contact you if there is a trial that you may be a qualified candidate for in the future. Please tell us a little bit about the types of trials you are interested in.
Please provide any other information you think we should know before a member of our team contacts you.

Dr. Eva Agaiby

President, Director of Clinical Trials & Regulatory Affairs

View Profile

Allen Banoub, MBA

Director of Marketing & Business Development

View Profile